Clinical trial · Interventional
New Food Solutions for Cancer Patients
Oncofood: New Food Solutions for Cancer Patients
NCT04302792CI-TRIAL-00052256OncofoodcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The ONCOFOOD project aims to design and develop new innovative food solutions for cancer patients, taking into account not only their nutritional requirements but also their sensory changes, promoting eating pleasure and preventing malnutrition. Research involving cancer patients but also their families and health care professionals is a key element of this approach to ensure the success of the developed products for the target group.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Patients | — | UNRESOLVED | — |
| Food Selection | — | UNRESOLVED | — |
| Taste Disorders | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Taste-optimised foods for cancer patients (Stage 3) | Behavioral | — | UNRESOLVED |
| Texture-modified foods for cancer patients (Stage 2) | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- NO_INTERVENTION
- label
- Stage 1: Interviews and focus group sessions
- description
- Group A: Cancer patients (requiring or have required texture-modified foods and/or experiencing or have experienced taste\&smell alterations in the last 12 months) will be required to attend a one-hour online interview. Group B: Relatives of cancer patients (requiring texture-modified foods and/or experiencing taste\&smell alterations) will be required to attend a 2-hour online focus group session. Group C: Healthcare professionals with a minimum of a year's experience with oncological patients that require texture-modified foods and/or have taste \& smell alteration will be required to attend a 2-hour online focus group session. A food diary will be given to Group A and B to complete for 7-days prior to their session. Topics to be discussed during the interview and the focus group sessions will include the food requirements of cancer patients, the barriers of the current food products, possible solutions to these requirements if any and their expectations towards new food solutions.
- type
- EXPERIMENTAL
- label
- Stage 2: Texture-modified foods for cancer patients
- description
- The study will involve conducting a tasting trial over a 2-weeks period where participants will be required to consume a maximum of three 3D printed texture-modified food based on the findings from Stage 1 and evaluate the food product by completing a structured questionnaire. Key questions areas covered by the questionnaire include appetite, sensory characteristics of the product (taste, flavour, mouthfeel/texture and smell), liking and acceptability, purchase intent and best place to buy the products; questions will involve rating scales as well as qualitative comments.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria:
1. Stage 1
1. Group A - Patients
* Adults 18-65 years old.
* Currently undergoing oncological treatment or have undergone oncological treatment in the last 12 months.
* Patients that require or have required texture-modified foods and/ or experience or have experienced taste \& smell alterations in the last 12 months.
2. Group B - Relatives and caregivers
* Over 18 years old.
* Relative or caregiver of an adult oncological patient (that require texture-modified foods and/ or experience taste \& smell alterations).
* Living/caring for someone that is currently undergoing or have undergone oncological treatment.
* Participates actively in cooking and buying food for a household of which the person currently undergoing oncological treatment is a member.
3. Group C - Healthcare professionals
* Dietitians, speech and language therapists, medical/clinical oncologists, cancer specialist nurses, and oncology social workers and counselors.
* Minimum of a year's experience with oncological patients that require texture-modified foods and/or having taste \& smell alterations.
2. Stage 2
* Adults 18-65 years old.
* Currently undergoing oncological treatment or have undergone oncological treatment in the last 12 months and require or have required texture-modified foods in the last 12 months.
* Individuals without dietary allergies or intolerances to the foods that will be tested in the study.
3. Stage 3
* Adults 18-65 years old.
* Currently undergoing oncological treatment or have undergone oncological treatment in the last 12 months and are experiencing or have experienced taste \& smell alterations in the last 12 months.
* Individuals without dietary allergies or intolerances to the foods that will be tested in the study.
Exclusion Criteria:
* Individuals below 18 years old will be excluded from the study.
* Individuals with dietary intolerances or allergies to the foods that will be tested in the study (Stages 2 and 3 only).
* Individuals who do not have the ability or capacity to consent.
* Individuals who are nil by mouth or have nasal gastric tubes of other feeding tubes inserted.
* Individuals who need modified solid and liquid diets due to problems with swallowing (Stage 3 only).References
Publications (4)
- BACKGROUNDTueros I, Uriarte M. Innovative food products for cancer patients: future directions. J Sci Food Agric. 2018 Mar;98(5):1647-1652. doi: 10.1002/jsfa.8789. Epub 2017 Dec 6. PMID 29168190
- BACKGROUNDWickham RS, Rehwaldt M, Kefer C, Shott S, Abbas K, Glynn-Tucker E, Potter C, Blendowski C. Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum. 1999 May;26(4):697-706. PMID 10337648
- BACKGROUNDLovell SJ, Wong HB, Loh KS, Ngo RY, Wilson JA. Impact of dysphagia on quality-of-life in nasopharyngeal carcinoma. Head Neck. 2005 Oct;27(10):864-72. doi: 10.1002/hed.20250. PMID 16114007
- BACKGROUNDAmezaga J, Alfaro B, Rios Y, Larraioz A, Ugartemendia G, Urruticoechea A, Tueros I. Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment. Support Care Cancer. 2018 Dec;26(12):4077-4086. doi: 10.1007/s00520-018-4277-z. Epub 2018 May 31. PMID 29855774